URETERAL NEOPLASM

This adverse event was reported 78 times

URETERAL NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MOSUNETUZUMAB 2 0.0018
1 CLEMASTINE FUMARATE 1 0.0007
2 IBRITUMOMAB TIUXETAN 1 0.0007
3 GALANTAMINE HYDROBROMIDE 1 0.0006
4 BACILLUS CALMETTE-GUERIN 1 0.0006
5 DAPRODUSTAT 1 0.0005
6 EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1 0.0003
7 FINERENONE 1 0.0003
8 ALOGLIPTIN 1 0.0003
9 EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE 1 0.0003
See all drugs enriched for association with URETERAL NEOPLASM